Authors: Verbeke R, Lentacker I, Smedt SC, DeWitte H DOI:10.1016/j.nantod.2019.100766 Abstract In the early nineties, pioneering steps were taken in the use of mRNA as a therapeutic tool for vaccination. In the following decades, an improved understanding of the mRNA pharmacology, together with novel insights in immunology have positioned mRNA-based technologies as next-generation vaccines. This [...]